Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR‑4‑mediated NF‑κB signal pathway.

Fang C, Xie L, Liu C, Fu C, Ye W, Liu H, Zhang B

Open source

DOI
10.3892/mmr.2018.9227
Published
2018 Aug
Container
Molecular medicine reports
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/mmr.2018.9227,
  title = {Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR‑4‑mediated NF‑κB signal pathway.},
  author = {Fang C and Xie L and Liu C and Fu C and Ye W and Liu H and Zhang B},
  year = {2018},
  journal = {Molecular medicine reports},
  doi = {10.3892/mmr.2018.9227},
  url = {https://doi.org/10.3892/mmr.2018.9227}
}

RIS

TY  - JOUR
TI  - Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR‑4‑mediated NF‑κB signal pathway.
AU  - Fang C
AU  - Xie L
AU  - Liu C
AU  - Fu C
AU  - Ye W
AU  - Liu H
AU  - Zhang B
PY  - 2018
JO  - Molecular medicine reports
DO  - 10.3892/mmr.2018.9227
UR  - https://doi.org/10.3892/mmr.2018.9227
ER  - 

APA

C, F., L, X., C, L., C, F., W, Y., H, L., & B, Z. (2018). Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR‑4‑mediated NF‑κB signal pathway.. Molecular medicine reports. https://doi.org/10.3892/mmr.2018.9227

Source records